Press release
Gene Therapy Market is expected to rise at a CAGR of 19.25% by 2032, estimates DelveInsight
Gene Therapy Market, DelveInsight
Advancements in technology, including portable designs, AI integration, and remote monitoring capabilities, are further boosting adoption by improving accuracy, usability, and patient outcomes. In addition, continuous innovation and new product launches by leading players worldwide are expanding the scope of available solutions. Together, these factors are strengthening the HFOT devices market by enhancing accessibility, efficiency, and effectiveness in respiratory care over the forecast period.
DelveInsight's Gene Therapy Market Insights report provides the current and forecast market analysis, individual leading Gene Therapy companies' market shares, challenges, Gene Therapy market drivers, barriers, and trends, and key Gene Therapy companies in the market.
Request for a sample page report @ https://www.delveinsight.com/report-store/gene-therapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Key Takeaways from the Gene Therapy Market Report
The Gene Therapy market is projected to grow at a moderate CAGR from 2025 to 2032.
As per DelveInsight estimates, North America is anticipated to dominate the global Gene Therapy market during the forecast period.
Notable Gene Therapy companies such as F. Hoffmann-La Roche Ltd., Novartis AG, Ferring B.V., bluebird bio, Inc., CSL, Ultragenyx Pharmaceutical Inc., PTC Therapeutics, BioMarin, Biogen, Prevail Therapeutics, Sarepta Therapeutics, Inc., Kriya Therapeutics, Affinia Therapeutics, Caribou Biosciences, Pfizer Inc., and several others are currently operating in the Gene Therapy market.
In November 2024, PTC Therapeutics received FDA approval for its gene therapy for AADC deficiency, marketed as KEBILIDITM (eladocagene exuparvovec-tneq), intended for use in both children and adults with the condition.
In June 2023, Sarepta Therapeutics, Inc. announced that the U.S. FDA granted accelerated approval for ELEVIDYS (delandistrogene moxeparvovec-rokl), a gene therapy designed for ambulatory pediatric patients aged 4 to 5 years with Duchenne muscular dystrophy (DMD) who have a confirmed mutation in the DMD gene.
To read more about the latest highlights related to the Gene Therapy market, get a snapshot of the key highlights entailed in the Global Gene Therapy Market Report https://www.delveinsight.com/sample-request/gene-therapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Gene Therapy Overview
The global gene therapy market is witnessing rapid growth, driven by the rising prevalence of rare and genetic disorders worldwide. Gene therapy offers a promising solution by targeting the root causes of diseases, delivering functional genes to correct or replace defective ones. Advances in viral vector technologies, CRISPR-based gene editing, and personalized medicine are enhancing the precision and efficacy of these treatments.
Gene Therapy Market Insights
North America is anticipated to hold the largest share of the gene therapy market in 2024 among all regions. This dominance is driven by the region's advanced healthcare infrastructure, robust R&D capabilities, and significant investments in innovative biopharmaceuticals. The rising prevalence of rare and genetic disorders, combined with the presence of leading market players such as Biogen, Novartis, and PTC Therapeutics, along with supportive government initiatives and favorable reimbursement policies, further reinforce North America's market position. Additionally, the rapid adoption of advanced gene therapy technologies and a well-established clinical trial pipeline-especially in the United States-are expected to propel market growth. The relatively higher incidence of genetic and rare diseases in the region also fuels demand for gene therapy solutions, solidifying its leadership in the market over the coming years.
According to the Centers for Disease Control and Prevention (2024), approximately 1 in 5,000 males aged 5-9 in the United States is affected by Duchenne or Becker muscular dystrophy (DBMD). These disorders arise from mutations in the dystrophin gene, resulting in progressive muscle weakness and functional decline. Gene therapy has the potential to target the root cause by delivering functional dystrophin genes or micro-dystrophin variants using viral vectors such as adeno-associated viruses (AAVs), further driving the growth of the gene therapy market in North America.
To know more about why North America is leading the market growth in the Gene Therapy market, get a snapshot of the Gene Therapy Market Outlook https://www.delveinsight.com/report-store/gene-therapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Gene Therapy Market Dynamics
According to the Haemophilia Foundation Australia (2024), over 7,400 people in Australia were diagnosed with bleeding disorders. Globally, haemophilia affects approximately 1 in 6,000-10,000 males, with haemophilia A occurring in 1 in 6,000 males and haemophilia B in 1 in 26,000 males. An estimated 830,895 individuals worldwide have haemophilia, including around 282,266 with severe cases. Gene therapy presents a promising solution by addressing the root cause of the disease through the delivery of functional genes that produce the missing clotting factors (Factor VIII for haemophilia A and Factor IX for haemophilia B). Therapies such as BioMarin's Roctavian for haemophilia A and UniQure's Hemgenix for haemophilia B have demonstrated potential to reduce or eliminate the need for factor replacement therapy, improve patients' quality of life, and correct underlying genetic defects. Consequently, the high global prevalence of haemophilia is expected to significantly drive the gene therapy market worldwide.
Additionally, the Haemophilia Foundation Australia (2024) reports that Von Willebrand disease (VWD), an inherited bleeding disorder affecting individuals of all genders and ethnicities, was diagnosed in over 2,500 people in Australia, though many cases likely remain undiagnosed. Given that VWD impacts both males and females and a significant portion of cases go undetected, the demand for innovative therapies is rising. Gene therapy offers a potential long-term or permanent solution by correcting or replacing faulty genes. Furthermore, the growing emphasis on personalized medicine and advancements in gene-editing technologies, including CRISPR, are accelerating the development of gene therapies targeting bleeding disorders such as VWD.
Gene Therapy Market Drivers:
Rising prevalence of genetic and rare diseases
Rapid expansion of the gene therapy pipeline
Increasing strategic activities among the key players across the globe
Get a sneak peek at the Gene Therapy market dynamics @ https://www.delveinsight.com/sample-request/gene-therapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Scope of the Gene Therapy Market Report:
Coverage: Global
Study Period: 2022 to 2032
Key Gene Therapy Companies: F. Hoffmann-La Roche Ltd., Novartis AG, Ferring B.V., bluebird bio, Inc., CSL, Ultragenyx Pharmaceutical Inc., PTC Therapeutics, BioMarin, Biogen, Prevail Therapeutics, Sarepta Therapeutics, Inc., Kriya Therapeutics, Affinia Therapeutics, Caribou Biosciences, Pfizer Inc., and others.
Which MedTech key players in the Gene Therapy market are set to emerge as the trendsetter, explore @ Gene Therapy Companies https://www.delveinsight.com/report-store/gene-therapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Leber's Hereditary Optic Neuropathy Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
Contact Info:
Kritika Rehani
Assistant Manager, Digital Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
www.delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene Therapy Market is expected to rise at a CAGR of 19.25% by 2032, estimates DelveInsight here
News-ID: 4148476 • Views: …
More Releases from DelveInsight Business Research LLP
Real World Evidence Solution Market is expected to rise at a CAGR of 8.07% by 20 …
The global real-world evidence (RWE) solutions market was valued at USD 2,832.33 million in 2024 and is projected to grow at a CAGR of 8.07% between 2025 and 2032, reaching USD 5,240.07 million by 2032. Market growth is primarily driven by the rising prevalence of chronic diseases and the increasing reliance on real-world data to understand their impact. Advancements in technologies such as big data analytics, artificial intelligence, and machine…
High Flow Oxygen Therapy Devices Market is expected to rise at a CAGR of 2.31% b …
The global high-flow oxygen therapy (HFOT) devices market is projected to expand at a CAGR of 2.31% between 2025 and 2032. Rising incidences of respiratory conditions such as COPD, asthma, pneumonia, and Acute Respiratory Distress Syndrome (ARDS) are driving demand for HFOT devices, as healthcare providers increasingly adopt non-invasive treatment options. At the same time, the growth of home healthcare and telemedicine is improving access to these devices, allowing patients…
Tumor Ablation Market is expected to rise at a CAGR of 13.3% by 2032, estimates …
The global tumor ablation market was valued at USD 1,703.26 million in 2024 and is projected to grow at a CAGR of 13.30% from 2025 to 2032, reaching USD 4,595.68 million by 2032. The increasing global burden of cancer is driving demand for effective treatment options such as tumor ablation. Rising adoption of minimally invasive procedures, due to benefits like reduced recovery times, lower complication risks, and cost efficiency compared…
Spinal Implants Market is expected to rise at a CAGR of 5.5% by 2032, estimates …
The global spinal implants market was valued at USD 14,324.12 million in 2024 and is projected to grow at a CAGR of 5.50% from 2025 to 2032, reaching USD 21,899.24 million by 2032. The increasing prevalence of spinal disorders, particularly among the elderly, is driving demand for surgical corrections. Additionally, the rise in sports-related and trauma-induced spinal injuries is contributing to the need for advanced implantable solutions. There is also…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
